6 results
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
or indirect use of funds of the Company or any of its Subsidiaries.
(oo) Cybersecurity. To the Company’s knowledge, the Company and its Subsidiaries
8-K
EX-1.1
HEPA
Hepion Pharmaceuticals Inc
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
that are made on the basis of data derived from such sources.
(aaa) Cybersecurity. The Company and its subsidiaries’ information technology assets
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.
(oo) Cybersecurity
8-K
EX-99.1
hdp046nrvi1m9n148
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
- Prev
- 1
- Next